{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:46:35Z","timestamp":1794249995041,"version":"4.9.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 1214PjF"],"award-info":[{"award-number":["20 1214PjF"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00991"],"award-info":[{"award-number":["2022-00991"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    As the non-coding genome remains poorly characterized in acute myeloid leukemia (AML), we aimed to identify and functionally characterize novel long non-coding RNAs (lncRNAs) relevant to AML biology and treatment. We first identified lncRNAs overexpressed in AML blasts and, among them, discovered a novel transcript, which we named\n                    <jats:italic>myeloid and AML-associated intergenic long non-coding RNA<\/jats:italic>\n                    (MALNC). MALNC is overexpressed in AML, particularly in cases with the\n                    <jats:italic>PML-RARA<\/jats:italic>\n                    fusion or\n                    <jats:italic>IDH2<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>R140<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>\/NPM1<\/jats:italic>\n                    co-mutations, and is associated with a distinct gene expression profile. Functional studies showed that\n                    <jats:italic>MALNC<\/jats:italic>\n                    knockout impairs AML cell proliferation and colony formation, enhances ATRA-induced differentiation, and sensitizes cells to arsenic trioxide. Transcriptomic analysis revealed that MALNC loss alters the expression of retinoic acid pathway genes, and chromatin binding studies showed that MALNC binds to genes related to the retinoic acid and Rho GTPase pathways. In conclusion, we have identified MALNC as a novel lncRNA that promotes leukemic cell proliferation, counteracts ATRA-induced differentiation, and modulates drug sensitivity in AML.\n                  <\/jats:p>","DOI":"10.1038\/s41417-025-00954-0","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T12:21:10Z","timestamp":1755951670000},"page":"1191-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MALNC: a new mutant NPM1\/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5311-7974","authenticated-orcid":false,"given":"Elisabetta","family":"Cozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Neddermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1872-1186","authenticated-orcid":false,"given":"Xiangfu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Mar\u00eda","family":"Gamboa-Cede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-2010","authenticated-orcid":false,"given":"Dimitris C.","family":"Kanellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"\u00d6sterroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2325-6012","authenticated-orcid":false,"given":"My","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nona","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1982-7712","authenticated-orcid":false,"given":"Alma","family":"Ma\u030ansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pandzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bengtze\u0301n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0695-0050","authenticated-orcid":false,"given":"Christer","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Fiskesund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-7156","authenticated-orcid":false,"given":"Panagiotis","family":"Baliakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Erkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli-Pekka","family":"Kallioniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lennartsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"954_CR1","doi-asserted-by":"crossref","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD Acute myeloid leukemia. Longo DL, editor. N Engl J Med. 2015;373:1136\u201352.","DOI":"10.1056\/NEJMra1406184"},{"key":"954_CR2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"954_CR3","first-page":"1354","volume":"9","author":"M-C Jiang","year":"2019","unstructured":"Jiang M-C, Ni J-J, Cui W-Y, Wang B-Y, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9:1354.","journal-title":"Am J Cancer Res"},{"key":"954_CR4","doi-asserted-by":"crossref","first-page":"D1034","DOI":"10.1093\/nar\/gky905","volume":"47","author":"Z Bao","year":"2019","unstructured":"Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q, Dong D. LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases. Nucleic Acids Res. 2019;47:D1034\u20137.","journal-title":"Nucleic Acids Res"},{"key":"954_CR5","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775\u201389.","journal-title":"Genome Res"},{"key":"954_CR6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"954_CR7","doi-asserted-by":"crossref","first-page":"18679","DOI":"10.1073\/pnas.1422050112","volume":"111","author":"R Garzon","year":"2014","unstructured":"Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan PS, et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci USA. 2014;111:18679\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"954_CR8","volume":"19","author":"H-H Huang","year":"2019","unstructured":"Huang H-H, Chen F-Y, Chou W-C, Hou H-A, Ko B-S, Lin C-T, et al. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer. 2019;19:617.","journal-title":"BMC Cancer"},{"key":"954_CR9","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2017.166215","volume":"102","author":"D Papaioannou","year":"2017","unstructured":"Papaioannou D, Nicolet D, Volinia S, Mr\u00f3zek K, Yan P, Bundschuh R, et al. Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. Haematologica. 2017;102:1391\u2013400.","journal-title":"Haematologica"},{"key":"954_CR10","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3324\/haematol.2017.171645","volume":"102","author":"E De Clara","year":"2017","unstructured":"De Clara E, Gourvest M, Ma H, Vergez F, Tosolini M, Dejean S, et al. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients. Haematologica. 2017;102:1718\u201326.","journal-title":"Haematologica"},{"key":"954_CR11","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/leu.2017.116","volume":"31","author":"Y Lyu","year":"2017","unstructured":"Lyu Y, Lou J, Yang Y, Feng J, Hao Y, Huang S, et al. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. Leukemia. 2017;31:2543\u201351.","journal-title":"Leukemia"},{"key":"954_CR12","unstructured":"Masoud Eslami M, Soufizomorrod M, Ahmadvand M High expression of long noncoding RNA NORAD is associated with poor clinical outcomes in non-M3 acute myeloid leukemia patients. Hematol Oncol Stem Cell Ther. 2021;1016."},{"key":"954_CR13","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.2147\/OTT.S222734","volume":"13","author":"R Zhang","year":"2020","unstructured":"Zhang R, Huo C-H. Long Noncoding RNA SOCS2-AS promotes leukemogenesis in FLT3-ITD+ acute myeloid leukemia through miRNA-221. Onco Targets Ther. 2020;13:2925\u201334.","journal-title":"Onco Targets Ther"},{"key":"954_CR14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.15252\/msb.20177834","volume":"13","author":"B Schmierer","year":"2017","unstructured":"Schmierer B, Botla SK, Zhang J, Turunen M, Kivioja T, Taipale J. CRISPR\/Cas9 screening using unique molecular identifiers. Mol Syst Biol. 2017;13:945.","journal-title":"Mol Syst Biol"},{"key":"954_CR15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ijlh.13225","volume":"42","author":"Y Yu","year":"2020","unstructured":"Yu Y, Kou D, Liu B, Huang Y, Li S, Qi Y, et al. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155. Int J Lab Hematol. 2020;42:464\u201372.","journal-title":"Int J Lab Hematol"},{"key":"954_CR16","first-page":"2203","volume":"18","author":"C Chen","year":"2019","unstructured":"Chen C, Wang P, Mo W, Zhang Y, Zhou W, Deng T, et al. lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia. Oncol Lett. 2019;18:2203\u201311.","journal-title":"Oncol Lett"},{"key":"954_CR17","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103350","volume":"24","author":"E Porc\u00f9","year":"2021","unstructured":"Porc\u00f9 E, Benetton M, Bisio V, Da Ros A, Tregnago C, Borella G, et al. The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics. iScience. 2021;24:103350.","journal-title":"iScience"},{"key":"954_CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/cdd.2016.111","volume":"24","author":"Z-H Chen","year":"2017","unstructured":"Chen Z-H, Wang W-T, Huang W, Fang K, Sun Y-M, Liu S-R, et al. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death Differ. 2017;24:212\u201324.","journal-title":"Cell Death Differ"},{"key":"954_CR19","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3390\/cancers13143440","volume":"13","author":"A Liquori","year":"2021","unstructured":"Liquori A, Iba\u00f1ez M, Sargas C, Sanz M\u00c1, Barrag\u00e1n E, Cervera J. Correction: liquori et al. Acute promyelocytic leukemia: a constellation of molecular events around a single PML-RARA fusion gene. Cancers 2020, 12, 624. Cancers. 2021;13:3440.","journal-title":"Cancers"},{"key":"954_CR20","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292\u2013302.","journal-title":"Blood"},{"key":"954_CR21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41375-019-0589-3","volume":"34","author":"L Cicconi","year":"2019","unstructured":"Cicconi L, Platzbecker U, Avvisati G, Paoloni F, Thiede C, Vignetti M, et al. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial. Leukemia. 2019;34:914\u20138.","journal-title":"Leukemia"},{"key":"954_CR22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2019.07.001","volume":"25","author":"MD McKenzie","year":"2019","unstructured":"McKenzie MD, Ghisi M, Oxley EP, Ngo S, Cimmino L, Esnault C, et al. Interconversion between tumorigenic and differentiated states in acute myeloid leukemia. Cell Stem Cell. 2019;25:258\u2013272.e9.","journal-title":"Cell Stem Cell"},{"key":"954_CR23","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","volume":"106","author":"S Schnittger","year":"2005","unstructured":"Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood. 2005;106:3733\u20139.","journal-title":"Blood"},{"key":"954_CR24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","volume":"109","author":"B Falini","year":"2007","unstructured":"Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood. 2007;109:874\u201385.","journal-title":"Blood"},{"key":"954_CR25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"954_CR26","doi-asserted-by":"crossref","unstructured":"Issa GC, DiNardo CD Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm. Blood Cancer J. 2021;11:107.","DOI":"10.1038\/s41408-021-00497-1"},{"key":"954_CR27","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1182\/bloodadvances.2022008282","volume":"7","author":"S Zarnegar-Lumley","year":"2023","unstructured":"Zarnegar-Lumley S, Alonzo TA, Gerbing RB, Othus M, Sun Z, Ries RE, et al. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis. Blood Adv. 2023;7:5941\u201353.","journal-title":"Blood Adv"},{"key":"954_CR28","doi-asserted-by":"crossref","first-page":"31613","DOI":"10.18632\/oncotarget.5148","volume":"6","author":"M D\u00edaz-Bey\u00e1","year":"2015","unstructured":"D\u00edaz-Bey\u00e1 M, Brunet S, Nomded\u00e9u J, Pratcorona M, Cordeiro A, Gallardo D, et al. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. Oncotarget. 2015;6:31613\u201327.","journal-title":"Oncotarget"},{"key":"954_CR29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/cancers11111638","volume":"11","author":"M Gourvest","year":"2019","unstructured":"Gourvest M, Brousset P, Bousquet M. Long noncoding RNAS in acute myeloid leukemia: functional characterization and clinical relevance. Cancers. 2019;11:1638.","journal-title":"Cancers"},{"key":"954_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13259-2","volume":"10","author":"D Papaioannou","year":"2019","unstructured":"Papaioannou D, Petri A, Dovey OM, Terreri S, Wang E, Collins FA, et al. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 2019;10:5351.","journal-title":"Nat Commun"},{"key":"954_CR31","first-page":"1013","volume":"53","author":"H Dong","year":"2018","unstructured":"Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye M, et al. Exosome-mediated transfer of lncRNA\u2011SNHG14 promotes trastuzumab chemoresistance in breast cancer. Int J Oncol. 2018;53:1013\u201326.","journal-title":"Int J Oncol"},{"key":"954_CR32","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/leu.2017.48","volume":"31","author":"M Wang","year":"2017","unstructured":"Wang M, Lindberg J, Klevebring D, Nilsson C, Mer AS, Rantalainen M, et al. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Leukemia. 2017;31:2029\u201336.","journal-title":"Leukemia"},{"key":"954_CR33","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","volume":"119","author":"G Juliusson","year":"2012","unstructured":"Juliusson G, Lazarevic V, H\u00f6rstedt A-S, Hagberg O, H\u00f6glund M. Group SALR. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119:3890\u20139.","journal-title":"Blood"},{"key":"954_CR34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djy021","volume":"110","author":"M Wang","year":"2018","unstructured":"Wang M, Lindberg J, Klevebring D, Nilsson C, Lehmann S, Gr\u00f6nberg H, et al. Development and validation of a novel RNA sequencing-based prognostic score for acute myeloid leukemia. J Natl Cancer Inst. 2018;110:1094\u2013101.","journal-title":"J Natl Cancer Inst"},{"key":"954_CR35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354\u201365.","journal-title":"Blood"},{"key":"954_CR36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. Acute myeloid leukemia, version 3.2017: clinical practice guidelines in oncology. JNCCN J Natl Compr Cancer Netw. 2017;15:926\u201357.","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"954_CR37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"954_CR38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"954_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"954_CR40","unstructured":"Chu C, Qu K, Zhong FL, Artandi SE, Chang HY Molecular cell resource genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions."},{"key":"954_CR41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38:276\u20138.","journal-title":"Nat Biotechnol"},{"key":"954_CR42","doi-asserted-by":"crossref","first-page":"W345","DOI":"10.1093\/nar\/gkm391","volume":"35","author":"L Kong","year":"2007","unstructured":"Kong L, Zhang Y, Ye Z-Q, Liu X-Q, Zhao S-Q, Wei L, et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007;35:W345\u20139.","journal-title":"Nucleic Acids Res"},{"key":"954_CR43","doi-asserted-by":"crossref","unstructured":"Maiga A, Lemieux S, Pabst C, Lavall\u00e9e VP, Bouvier M, Sauvageau G, et al. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets. Blood Cancer J. 2016;6:e431.","DOI":"10.1038\/bcj.2016.36"},{"key":"954_CR44","doi-asserted-by":"crossref","first-page":"W280","DOI":"10.1093\/nar\/gkh355","volume":"32","author":"I Ovcharenko","year":"2004","unstructured":"Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 2004;32:W280\u20136.","journal-title":"Nucleic Acids Res"},{"key":"954_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9112423","volume":"9","author":"J Albanesi","year":"2020","unstructured":"Albanesi J, Noguera NI, Banella C, Colangelo T, De Marinis E, Leone S, et al. Transcriptional and metabolic dissection of ATRA-induced granulocytic differentiation in NB4 acute promyelocytic leukemia cells. Cells. 2020;9:1\u201325.","journal-title":"Cells"},{"key":"954_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2015-07-604496","volume":"127","author":"D Grimwade","year":"2016","unstructured":"Grimwade D, Ivey A, Huntly BJP. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127:29\u201341.","journal-title":"Blood"},{"key":"954_CR47","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/s41375-021-01222-4","volume":"35","author":"B Falini","year":"2021","unstructured":"Falini B, Sciabolacci S, Falini L, Brunetti L, Martelli MP. Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field. Leukemia. 2021;35:3113\u201326.","journal-title":"Leukemia"},{"key":"954_CR48","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/leu.2017.30","volume":"31","author":"EM Heath","year":"2017","unstructured":"Heath EM, Chan SM, Minden MD, Murphy T, Shlush LI, Schimmer AD. Biological and clinical consequences of NPM1 mutations in AML. Leuk. 2017;31:798\u2013807.","journal-title":"Leuk"},{"key":"954_CR49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.thj.6200216","volume":"4","author":"SB van Waalwijk van Doorn-Khosrovani","year":"2003","unstructured":"van Waalwijk van Doorn-Khosrovani SB, Erpelinck C, Meijer J, van Oosterhoud S, van Putten WLJ, Valk PJM, et al. Biallelic mutations in the CEBPA gene low CEBPA expression levels as prognostic markers in intermediate-risk AML. Hematol J. 2003;4:31\u201340.","journal-title":"Hematol J"},{"key":"954_CR50","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2009-03-213389","volume":"114","author":"S Schnittger","year":"2009","unstructured":"Schnittger S, Kern W, Tschulik C, Weiss T, Dicker F, Falini B, et al. Minimal residual disease levels assessed by NPM1 mutation\u2013specific RQ-PCR provide important prognostic information in AML. Blood. 2009;114:2220\u201331.","journal-title":"Blood"},{"key":"954_CR51","first-page":"dju505","volume":"107","author":"T Kim","year":"2015","unstructured":"Kim T, Jeon Y-J, Cui R, Lee J-H, Peng Y, Kim S-H, et al. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst. 2015;107:dju505.","journal-title":"J Natl Cancer Inst"},{"key":"954_CR52","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov. 2015;5:1024\u201339.","journal-title":"Cancer Discov"},{"key":"954_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","volume":"19","author":"CV Dang","year":"1999","unstructured":"Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1\u201311.","journal-title":"Mol Cell Biol"},{"key":"954_CR54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428194.2018.1464158","volume":"60","author":"M Ohanian","year":"2019","unstructured":"Ohanian M, Rozovski U, Kanagal-Shamanna R, Abruzzo LV, Loghavi S, Kadia T, et al. MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma. 2019;60:37\u201348.","journal-title":"Leuk Lymphoma"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00954-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:03:21Z","timestamp":1763334201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00954-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00954-0","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AML patient samples and healthy donor samples were collected after informed consent and in accordance with the Declaration of Helsinki. The study was approved by the Stockholm ethical review board, part of the Swedish Ethical Review Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declaration"}}]}}